Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Bevacizumab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 49 Ovarian Neoplasms 29 Carcinoma, Hepatocellular 24 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Fallopian Tube Neoplasms 15 Colonic Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Rectal Neoplasms 7 Lung Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Recurrence 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Colorectal Cancer Metastatic 4 Advanced Solid Tumors 4 Squamous Cell Carcinoma of Head and Neck 3 Medulloblastoma 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Pancreatic Ductal 3

Interventions

Dexamethasone 8 Lenalidomide 7 Bortezomib 5 pomalidomide 3 carfilzomib 3 Calcium Dobesilate 3 Prednisone 2 poly ICLC 1 ibrutinib 1 fludarabine 1 elotuzumab 1 daratumumab 1 citarinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Sirolimus 1 PVX-410 vaccine 1 Mycophenolic Acid 1 Melphalan 1 Granulocyte Colony-Stimulating Factor 1 Everolimus 1 Cyclophosphamide 1 Clonal Hematopoiesis 1 Chromatin Immunoprecipitation Sequencing 1 Blood Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡